Video
Pressconference video
On 12 June 2024, the Medical University - Varna organized a workshop named "Computational and Experimental Systems Medicine", funded by the National Recovery and Resilience Plan (NRRP) (MUVE-TEAM project; Contract BG-RRP-2.004-0009-C0). The event brought together some of the leading European scientists in cancer genomics, transcriptomics and proteomics, as well as young researchers and postdocs from MU-Varna. The speakers presented the latest methods for high-throughput processing of large datasets in biomedicine.
“Our goal is to introduce young scientists to a new group of accessible methods applicable not only to oncology but also to fields such as neurology and cardiovascular medicine," outlined Prof. Dr. Anton Tonchev, Director of the Research Institute of MU-Varna and co-organizer of the event. He highlighted the vast database of patients' medical data available for research, made possible through the so-called high-throughput technologies, whose processing requires the use of machine learning and artificial intelligence. The event attracted scientists from various fields such as morphology, cell biology, biochemistry, genetics, biomedical imaging.
During the workshop, Prof. Vessela Kristensen from the University of Oslo, Norway (co-organizer of the event), Prof. Dr. Anton Tonchev, Head of the Research Institute at MU-Varna, Prof. Arnoldo Frigessi, Director of the Centre of Excellence “Integreat", in Oslo, Norway, and Prof. Juha Klefström from the Finnish Cancer Institute in Helsinki, Finland, presented to the media findings in cancer immunology that contribute to the prevention, diagnosis, and treatment of neoplastic diseases. The scientists answered questions regarding advancements in modern science and their implications for patients in Bulgaria and Europe. They believe that digital modeling of tumors, including the creation of “digital twins", will further improve personalized patient care.
